---
figid: PMC7401253__marinedrugs-18-00347-g005
figlink: pmc/articles/PMC7401253/figure/marinedrugs-18-00347-f005/
number: F5
caption: A scheme highlighting the pathophysiology of neurodegenerative disorders
  and post-ischemic consequences along with indicating the underlying mechanism of
  neuroprotective action of algal compounds. The numeric symbols indicate the points
  of pharmacological action that include (1) inhibition of cytokine secretion from
  activated microglia by fucoxanthin, fucosterol, fucoidan, dieckol, phlorofucofuroeckol
  and bieckol, κ-carrageenan, floridoside and seleno-polymannarate, (2) attenuation
  of inflammatory response via inhibition of NF-κB pathway by eckol, dieckol and 8,8-bieckol,
  (3) priming of antioxidant defense system via activation of Nrf2/ARE pathway (blocking
  interaction between Nrf2 and Keap1) by fucoxanthin, fucoidan and zonarol, (4) Reduction
  of apoptosis via inhibiting pro-apoptotic JNK/Erk pathway by dimethylsulfoniopropionate
  and κ-carrageenan-derived pentasaccharide, (5) Inhibition of glutamate-induced Ca2+
  influx via blocking extrasynaptic GluN2B by fucoidan and tramiprosate, (6) Activation
  of BDNF-dependent pro-survival pathway via inducing PI3K/Akt or TrkB/ERK signaling
  by fucoxanthin and fucosterol, (7) Attenuation of I/R-injury via preventing excitotoxic
  depolarization by C-phycocyanin, (8) Inhibition of nNOS sequestration by tramiprosate,
  (9) proteasomal degradation by fucoidan, (10) Induction of autophagy/mitophagy by
  fucoxanthin, (11) anticholinesterase activity by fucoidan, fucoxanthin, dieckol
  and phlorofucofuroeckol, (12) anti-amyloidogenesis via blocking β-secretase activity
  by fucoxanthin, fucosterol and glycoprotein, and (13) Aβ-clearance via enhancing
  the transcription of ApoE and ABC transporters genes by fucosterol, saringasterol,
  and alginate-derived oligosaccharide. NF-κB/p50-pp65, nuclear factor kappa-light-chain-enhancer
  of activated B cells; Nrf2, nuclear factor erythroid 2-related factor 2; ARE, antioxidant
  response element; IkB, inhibitor of NF-κB; Keap1, Kelch-like ECH-associated protein
  1; JNK, c-Jun N-terminal kinases; GluN2B, N-methyl D-aspartate receptor subtype
  2B; PI3K, phosphoinositide 3-kinases; Akt, protein kinase B; MEK1/2, mitogen-activated
  protein kinase kinase; ERK, extracellular signal-regulated kinases; TrkB, tropomyosin
  receptor kinase B; CREB, cAMP-response element binding protein; CRE, cAMP response
  elements; BDNF, Brain-derived neurotrophic factor; AChE, acetylcholinesterase; Ach,
  acetylcholine; ABCA1, ATP-binding cassette transporter A1; nNOS, neuronal nitric
  oxide synthase; ROS, reactive oxygen species; ψ, mitochondrial membrane potential.
pmcid: PMC7401253
papertitle: 'Neuroprotective Potentials of Marine Algae and Their Bioactive Metabolites:
  Pharmacological Insights and Therapeutic Advances.'
reftext: Md. Abdul Hannan, et al. Mar Drugs. 2020 Jul;18(7):347.
pmc_ranked_result_index: '59187'
pathway_score: 0.9569842
filename: marinedrugs-18-00347-g005.jpg
figtitle: Scheme highlighting the pathophysiology of neurodegenerative disorders and
  post-ischemic consequences along with indicating the underlying mechanism of neuroprotective
  action of algal compounds
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7401253__marinedrugs-18-00347-g005.html
  '@type': Dataset
  description: A scheme highlighting the pathophysiology of neurodegenerative disorders
    and post-ischemic consequences along with indicating the underlying mechanism
    of neuroprotective action of algal compounds. The numeric symbols indicate the
    points of pharmacological action that include (1) inhibition of cytokine secretion
    from activated microglia by fucoxanthin, fucosterol, fucoidan, dieckol, phlorofucofuroeckol
    and bieckol, κ-carrageenan, floridoside and seleno-polymannarate, (2) attenuation
    of inflammatory response via inhibition of NF-κB pathway by eckol, dieckol and
    8,8-bieckol, (3) priming of antioxidant defense system via activation of Nrf2/ARE
    pathway (blocking interaction between Nrf2 and Keap1) by fucoxanthin, fucoidan
    and zonarol, (4) Reduction of apoptosis via inhibiting pro-apoptotic JNK/Erk pathway
    by dimethylsulfoniopropionate and κ-carrageenan-derived pentasaccharide, (5) Inhibition
    of glutamate-induced Ca2+ influx via blocking extrasynaptic GluN2B by fucoidan
    and tramiprosate, (6) Activation of BDNF-dependent pro-survival pathway via inducing
    PI3K/Akt or TrkB/ERK signaling by fucoxanthin and fucosterol, (7) Attenuation
    of I/R-injury via preventing excitotoxic depolarization by C-phycocyanin, (8)
    Inhibition of nNOS sequestration by tramiprosate, (9) proteasomal degradation
    by fucoidan, (10) Induction of autophagy/mitophagy by fucoxanthin, (11) anticholinesterase
    activity by fucoidan, fucoxanthin, dieckol and phlorofucofuroeckol, (12) anti-amyloidogenesis
    via blocking β-secretase activity by fucoxanthin, fucosterol and glycoprotein,
    and (13) Aβ-clearance via enhancing the transcription of ApoE and ABC transporters
    genes by fucosterol, saringasterol, and alginate-derived oligosaccharide. NF-κB/p50-pp65,
    nuclear factor kappa-light-chain-enhancer of activated B cells; Nrf2, nuclear
    factor erythroid 2-related factor 2; ARE, antioxidant response element; IkB, inhibitor
    of NF-κB; Keap1, Kelch-like ECH-associated protein 1; JNK, c-Jun N-terminal kinases;
    GluN2B, N-methyl D-aspartate receptor subtype 2B; PI3K, phosphoinositide 3-kinases;
    Akt, protein kinase B; MEK1/2, mitogen-activated protein kinase kinase; ERK, extracellular
    signal-regulated kinases; TrkB, tropomyosin receptor kinase B; CREB, cAMP-response
    element binding protein; CRE, cAMP response elements; BDNF, Brain-derived neurotrophic
    factor; AChE, acetylcholinesterase; Ach, acetylcholine; ABCA1, ATP-binding cassette
    transporter A1; nNOS, neuronal nitric oxide synthase; ROS, reactive oxygen species;
    ψ, mitochondrial membrane potential.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NOS1
  - NOS2
  - NOS3
  - RPL17
  - TNF
  - FGFR3
  - ACHE
  - APOE
  - SYNE1
  - PSMD2
  - IKBKG
  - APP
  - HRAS
  - KRAS
  - NRAS
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - AKT2
  - AKT3
  - AKT1
  - MAPK3
  - MAPK1
  - GPX1
  - GPX4
  - GPX7
  - GPX8
  - GPX2
  - GPX3
  - GPX5
  - GPX6
  - SOD2
  - SOD1
  - SOD3
  - IL18
  - BDNF
  - Acetate
  - Choline
  - Glutamate
  - NMDA
  - ATP
  - NO01
  - "Jschamiarupurtfusion \x1F injury \x1F Excitetoxic"
  - Neurodegenerative Disorders
  - AD
  - PD
genes:
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS1
  entrez: '4842'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS2
  entrez: '4843'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: L-17
  symbol: L17
  source: hgnc_alias_symbol
  hgnc_symbol: RPL17
  entrez: '6139'
- word: TNFa
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: Ach
  symbol: ACH
  source: hgnc_prev_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: AchE
  symbol: ACHE
  source: hgnc_symbol
  hgnc_symbol: ACHE
  entrez: '43'
- word: TNF-
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: ApoE
  symbol: APOE
  source: hgnc_symbol
  hgnc_symbol: APOE
  entrez: '348'
- word: ARCA1
  symbol: ARCA1
  source: hgnc_alias_symbol
  hgnc_symbol: SYNE1
  entrez: '23345'
- word: TRAP2
  symbol: TRAP2
  source: hgnc_alias_symbol
  hgnc_symbol: PSMD2
  entrez: '5708'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: App
  symbol: APP
  source: hgnc_symbol
  hgnc_symbol: APP
  entrez: '351'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: GPx
  symbol: GPX
  source: bioentities_symbol
  hgnc_symbol: GPX1
  entrez: '2876'
- word: GPx
  symbol: GPX
  source: bioentities_symbol
  hgnc_symbol: GPX4
  entrez: '2879'
- word: GPx
  symbol: GPX
  source: bioentities_symbol
  hgnc_symbol: GPX7
  entrez: '2882'
- word: GPx
  symbol: GPX
  source: bioentities_symbol
  hgnc_symbol: GPX8
  entrez: '493869'
- word: GPx
  symbol: GPX
  source: bioentities_symbol
  hgnc_symbol: GPX2
  entrez: '2877'
- word: GPx
  symbol: GPX
  source: bioentities_symbol
  hgnc_symbol: GPX3
  entrez: '2878'
- word: GPx
  symbol: GPX
  source: bioentities_symbol
  hgnc_symbol: GPX5
  entrez: '2880'
- word: GPx
  symbol: GPX
  source: bioentities_symbol
  hgnc_symbol: GPX6
  entrez: '257202'
- word: SOD
  symbol: SOD
  source: bioentities_symbol
  hgnc_symbol: SOD2
  entrez: '6648'
- word: SOD
  symbol: SOD
  source: bioentities_symbol
  hgnc_symbol: SOD1
  entrez: '6647'
- word: SOD
  symbol: SOD
  source: bioentities_symbol
  hgnc_symbol: SOD3
  entrez: '6649'
- word: TNFa
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: BDNF
  symbol: BDNF
  source: hgnc_symbol
  hgnc_symbol: BDNF
  entrez: '627'
chemicals:
- word: Acetate
  source: MESH
  identifier: D000085
- word: Choline
  source: MESH
  identifier: D002794
- word: Glutamate
  source: ''
  identifier: ''
- word: NMDA
  source: ''
  identifier: ''
- word: ATP
  source: MESH
  identifier: D000255
- word: NO01
  source: MESH
  identifier: C519584
diseases:
- word: "Jschamiarupurtfusion \x1F injury \x1F Excitetoxic"
  source: MESH
  identifier: D058186
- word: Neurodegenerative Disorders
  source: MESH
  identifier: D019636
- word: AD
  source: MESH
  identifier: D000544
- word: PD
  source: MESH
  identifier: D010300
figid_alias: PMC7401253__F5
redirect_from: /figures/PMC7401253__F5
figtype: Figure
---
